TRPM8 Antagonism with Elismetrep: A Novel Approach for Treating Migraine - Part 1
In part one of this series, Dr. Tesha Monteith and Dr. Brett Lauring discuss the potential role TRPM8 antagonist may play in the management of migraine. Read more about this abstract on the AAN…
Read the full articleYou might also wanna read
Real-world study suggests GLP-1 receptor agonists may reduce emergency visits and medication needs for chronic migraine
Real-world data suggest GLP-1 receptor agonists may reduce emergency care visits and the need for additional migraine treatments in adults w
mdsc.pe·7d agoRimegepant Effective in Treatment-Resistant Migraine
Rimegepant is safe and effective in patients with migraine not responding to multiple prior preventive therapies, a real-world study shows.
Medscape·2d ago
Intranasal Zavegepant for the acute treatment of migraine in adults: A review of randomized clinical trials
Migraine is a highly prevalent chronic neurological disorder and one of the leading causes of disability worldwide. Among recent therapeutic
rsdjournal.org·13d ago
Study to Assess Effectiveness of Oral Atogepant in Adult Participants For Prevention of Migraine in the United Kingdom
Conditions : Migraine Sponsors : AbbVie Not yet recruiting
clinicaltrials.gov·9d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.